Aptose Bioscns (APTO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2009 | 09-2009 | 06-2009 | 03-2009 | 12-2008 | |
Sales | 74 | 41 | 64 | 52 | 48 |
Gross Profit | 70 | 40 | 64 | 50 | 48 |
Operating Expenses | 1,240 | 1,060 | 0 | 1,630 | 0 |
Operating Income | -1,166 | -1,019 | 64 | -1,578 | 48 |
Interest Expense | 10 | 20 | 0 | 120 | 0 |
Other Income | -4 | 9,809 | 0 | -302 | 0 |
Pre-tax Income | -1,180 | 8,770 | 64 | -2,000 | 48 |
Net Income Continuous | -1,188 | 8,776 | -1,563 | -2,004 | 2,793 |
Net Income | $-1,188 | $8,776 | $-1,563 | $-2,004 | $2,793 |
EPS Basic Total Ops | -50.40 | 196.18 | -43.20 | -43.20 | 54.05 |
EPS Basic Continuous Ops | -51.21 | 196.33 | -43.66 | -43.66 | 60.32 |
EPS Diluted Total Ops | -50.40 | 196.18 | -43.20 | -43.20 | 54.05 |
EPS Diluted Continuous Ops | -51.21 | 196.33 | -43.66 | -43.66 | 60.32 |
EBITDA(a) | $-1,136 | $-1,169 | $114 | $-1,468 | $48 |